Chronic Obstructive Pulmonary Disease

Tavulus (tiotropium bromide) DPI was launched in Spain to treat chronic obstructive pulmonary disease(COPD)

MUMBAI, India, Oct. 11, 2021 Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spain, for the treatment of chronic obstructive pulmonary disease (COPD). In November 2017, a Glenmark European…